Uterine cancer vaccine generally refers to the human papillomavirus (HPV) vaccine, HPV bivalent, HPV quadrivalent, HPV nine-valent vaccine difference in the prevention of different types of viruses and diseases, applicable to different groups, 1. HPV bivalent vaccine: HPV bivalent vaccine can be used to prevent HPV16 subtypes, HPV18 subtypes, HPV31 subtypes, HPV33 subtypes, HPV45 subtypes. Generally HPV bivalent vaccine can prevent 70% of cervical cancer. And HPV bivalent vaccine is suitable for women aged 9~45 years old. 2. HPV quadrivalent vaccine: HPV quadrivalent vaccine can prevent HPV11 subtypes, HPV6 subtypes, HPV18 subtypes. In addition, HPV quadrivalent vaccine has cross-protection against HPV subtypes 33, 45, and 31. HPV quadrivalent vaccine can be used against more than 90% of genital warts and 70% of cervical cancers. In addition, HPV quadrivalent vaccine is suitable for women aged 9 to 45 years old. 3. HPV 9-valent vaccine: HPV 9-valent vaccine is generally used to prevent HPV subtype 16, HPV subtype 11, HPV subtype 58, HPV subtype 31, HPV subtype 33, HPV subtype 6, HPV subtype 45. HPV 9-valent vaccine can be used to prevent more than 90% of genital warts, and 90% of cervical cancers. In addition, the nine-valent vaccine is suitable for women aged 16 to 26 years. For women who are ready to take HPV vaccine need to consult their doctors in time, and the doctors will choose the right HPV vaccine according to the women’s condition.